相关实验视频

Updated: Jun 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

莫尔努皮拉维尔:作用机制,临床和翻译科学

Brian M Maas¹, Julie Strizki¹, Randy R Miller¹

¹Merck & Co., Inc., Rahway, New Jersey, USA.

Clinical and translational science

|April 9, 2024

概括

口服抗病毒药物Molnupiravir通过将错误引入病毒RNA基因组,有效地减少COVID-19患者的住院和死亡. 这种治疗证明了显著的临床益处和对SARS-CoV-2的高耐药性障碍.

科学领域:

病毒学病毒学
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

莫尔努皮拉维尔是N-基丁 (NHC) 的口服前药物,是一种具有广泛抗病毒活性的核酸相似物.
在细胞内,NHC被化成NHC-三酸盐 (NHC-TP),该三酸盐会抑制病毒RNA依赖RNA聚合酶 (RdRp).
莫尔努皮拉维尔已经显示出对SARS-CoV-2的有效性,对抗性发展的障碍很高.

研究的目的:

评估molnupiravir及其代谢物NHC.的药理动力学和药理动力学特性.
评估molnupiravir在非住院COVID-19患者中的临床疗效.
分析molnupiravir对病毒载量和临床结果的影响.

主要方法:

莫尔努皮拉维尔和NHC的血度和半衰期的药理动力学分析.
在非住院COVID-19患者接受每天两次800毫克molnupiravir的III期临床试验 (MOVE-OUT).
与安慰剂相比,住院,死亡,病毒载量减少和临床结果的评估.

主要成果:

莫尔努皮拉维尔迅速化为NHC,峰值度在1.5小时,有效半衰期为3.3小时.
NHC-TP积累支持每天两次剂量,因为度概况更平坦.
在MOVE-OUT研究中,与安慰剂相比,molnupiravir治疗的患者的住院治疗或死亡率显著减少.
摩尔努皮拉维尔治疗导致SARS-CoV-2病毒载量减少较大,并改善了临床结果.

结论:

莫尔努皮拉维尔是一种有效的口服抗病毒药物,用于COVID-19,减少严重的结果.
药物的机制包括通过NHC-TP诱导病毒基因组错误.
现实世界的证据研究和全球授权支持molnupiravir.vir的临床实用性.

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

相关概念视频

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...